London, Apr 30 - Scientists have identified a gene that slows the spread of pancreatic cancer tumours, a finding they say could lead to new targeted treatments for the deadliest disease.
An international team of researchers found that the gene, called USP9x, is switched off in some pancreatic cancer cells mice. But when turned on, the gene stops cancerous cells from dividing uncontrollably, the researchers said.
The gene is not mutated, but other proteins and chemicals become stuck to it and turn the gene off.
Drugs having the potential to turn the gene back on can help stop the spread of the fifth most deadly cancer that affects nearly 8,000 people in the UK alone every year.
Prof David Tuveson, of the Cancer Research UK Cambridge Research Institute, said: ÒWe suspected that the fault wasn't in the genetic code at all, but in the chemical tags on the surface of the DNA that switch genes on and off, and by running more lab tests we were able to confirm this.
ÒDrugs which strip away these tags are already showing promise in lung cancer and this study suggests they could also be effective,Ó Prof Tuveson was quoted as saying by the BBC.
Dr David Adams, from the Wellcome Trust Sanger Institute, said: ÒThis study strengthens our emerging understanding that we must also look into the biology of cells to identify all the genes that play a role in cancer.Ó They argue that up to 15 per cent of pancreatic cancers could be down the turning this one gene off.
ÒThese results raise the possibility that a class of promising new cancer drugs may be effective at treating some pancreatic cancers,Ó added Dr Julie Sharp, Cancer Research UK's senior science information manager.
The study is published in the journal Nature.
Showing posts with label Cancer. Show all posts
Showing posts with label Cancer. Show all posts
Monday, April 30, 2012
Wednesday, March 28, 2012
'70% Indians in 30-69 age group fell prey to cancer in 2010'
New Delhi, (India) March 28, 2012 - Over 70 per cent of people in the age group of 30-69 have fallen prey to cancer in India in 2010, with tobacco-related and cervical cancers being the leading cause of deaths, according to a new study.
According to the study published in 'The Lancet' today, there were 556,400 cancer deaths across India in 2010, of which 71 per cent (3,95,000) deaths occurred in people aged between 30-69 years (2,00,100 men and 1,95,300 women).
At nearly 23 per cent, oral cancer caused the most deaths in men, followed by stomach cancer (12.6 per cent) and lung cancer (11.4 per cent), while cervical cancer was the leading cause (17 per cent) of death in women followed by breast cancer (10.2 per cent).
The authors, who analysed over 1,22,400 deaths in 6,671 small areas over a period of three years, found that 42 per cent male and 183 per cent female died due to tobacco-related cancers in 2010.
Lead study author Professor Prahbat Jha of the Centre for Global Health Research at the University of Toronto in Canada said, ÒCancer appears to be a disease of the young in India as it kills over 70 per cent of people in middle age...cancer deaths are two times higher in the least educated than the most educated and the differences were similar between urban and rural areas.Ó ÒMost cancer deaths were tobacco-related and our study provides a road-map for a strong anti-tobacco policy by the government of India and higher taxes on tobacco can be an effective measure, which studies have shown to be the single most effective measure to reduce smoking,Ó he said.
According to the study published in 'The Lancet' today, there were 556,400 cancer deaths across India in 2010, of which 71 per cent (3,95,000) deaths occurred in people aged between 30-69 years (2,00,100 men and 1,95,300 women).
At nearly 23 per cent, oral cancer caused the most deaths in men, followed by stomach cancer (12.6 per cent) and lung cancer (11.4 per cent), while cervical cancer was the leading cause (17 per cent) of death in women followed by breast cancer (10.2 per cent).
The authors, who analysed over 1,22,400 deaths in 6,671 small areas over a period of three years, found that 42 per cent male and 183 per cent female died due to tobacco-related cancers in 2010.
Lead study author Professor Prahbat Jha of the Centre for Global Health Research at the University of Toronto in Canada said, ÒCancer appears to be a disease of the young in India as it kills over 70 per cent of people in middle age...cancer deaths are two times higher in the least educated than the most educated and the differences were similar between urban and rural areas.Ó ÒMost cancer deaths were tobacco-related and our study provides a road-map for a strong anti-tobacco policy by the government of India and higher taxes on tobacco can be an effective measure, which studies have shown to be the single most effective measure to reduce smoking,Ó he said.
Monday, February 13, 2012
Beauty Products and Cancer: Know the Facts
BETHESDA, Md., Feb. 13, 2012- Have you dyed or relaxed your hair? Do you put on lipstick before you head out to work? Do you paint your nails? Many Hispanic women have a beauty routine or beauty products that they regularly use. Have you ever worried that yours might increase your risk for cancer? Before you panic and cancel your appointment at the salon, read on—it's time to break down some beauty-related cancer fact and fiction.
Hair Dye: It is estimated that more than one-third of women over age 18 and about 10 percent of men over age 40 use some type of hair dye. Hair dyes are full of chemicals—5,000, to be precise—and that hasn't escaped the notice of cancer researchers. Decades ago, researchers began studying chemicals used in hair dye. They found that early dye formulations contained chemicals that could cause cancer in animals. Not surprisingly, manufacturers changed the formulas and eliminated some of these chemicals in the United States around 1980. Because so many people use hair dyes, researchers continue to monitor whether chemicals in hair coloring products can increase risk for cancer in humans.According to the National Cancer Institute (NCI), the evidence for increased risks for cancer from modern hair dyes use is limited and inconsistent. Some studies have indicated that people who used hair dyes had an increased risk for bladder and breast cancer, as well as cancers of the blood and bone marrow (such as non-Hodgkin lymphoma and leukemia), while other studies have not. Based on its review of the evidence, the Working Group of the International Agency for Research on Cancer (IARC) concluded that personal use of hair dyes is "not classifiable" as cancer-causing to humans. So it is still unclear if personal use of hair dyes can increase your risk for cancer. If you would like to learn more about hair dye and health risks, the Outreach and Information Center of the U.S. Food and Drug Administration's Center for Food Safety and Applied Nutrition has information about hair dyes and how they are regulated. Visit http://www.fda.gov/Food/default.htm (search term: hair dye).
Hair Straightening: If you or your stylist uses hair smoothing or straightening products keep in mind that some of these products contain formaldehyde. Although formaldehyde is naturally occurring and is also used widely in many consumer products, this chemical is a known human carcinogen (cancer-causing substance) and can also cause skin irritation and sensitization. People can be exposed to formaldehyde in the workplace and in their home environment, but the highest levels are found in work settings where formaldehyde is produced or used. In a salon, formaldehyde levels are elevated when formaldehyde-containing products are being applied, but they quickly return to a lower level. Remember that although your cancer risk from these hair products may be low, both hair dyes and straightening products contain chemicals that can hurt your skin, hair, and eyes especially if you are not careful or do not use them as intended. To learn more about the short-term and long-term risks of formaldehyde, visit www.cancer.gov (search term: formaldehyde).
Nail Products: When you head in for a manicure and you see the manicurist wearing a dust mask, you may have wondered about your own safety too. Nail salon workers wear dust masks to minimize breathing in dust particles when filing or shaping artificial nail enhancements. Dust masks are intended to prevent inhalation of dust, but they do not protect against inhalation of chemicals. Professional nail care products are typically formulated to minimize exposure to hazardous chemicals that may cause adverse health effects. However, overexposure may occur and could result in skin irritation, allergic reaction, or serious eye injury. If you work at a nail salon, own a salon, or just want to learn more, check out the publication Protecting the Health of Nail Salon Workers by the U.S. Environmental Protection Agency. The publication helps workers understand product ingredients and how to prevent overexposure to those that present potential health risks. As with any cosmetic product that may be hazardous if misused, you should read labels of nail products carefully and heed any warnings. But as far as cancer is concerned, there is no known risk associated with using nail products. To read more about safety information for nail products, visit www.fda.gov (search term: nail products).
Lipstick: Some of the natural colors used in lipstick contain trace amounts of lead. The National Toxicology Program (NTP) of the National Institute of Environmental Health Sciences of the National Institutes of Health says that lead and lead products are "reasonably anticipated to be human carcinogens." However, the Food and Drug Administration (FDA) has assessed the potential for harm to consumers from use of lipstick containing lead and determined that there is no safety concern because lipstick is intended for topical use and is only ingested incidentally and in small quantities. Always use your lipstick only as directed and keep the products away from children. Visit www.fda.gov (search term: lipstick) for more.
With all the news coverage out there claiming this product or that product may cause cancer, it sometimes may be hard to figure out what's safe, what's hazardous, and what's plain, old sensationalized. One way to minimize the damage and fear caused by misinformation is to identify respected sources—such as the National Cancer Institute (www.cancer.gov) or Food and Drug Administration—and use them as primary resources for your health information. Knowing the facts is one way to keep your beauty routine good-looking inside and out.
NCI leads the National Cancer Program and the NIH effort to dramatically reduce the burden of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI web site at www.cancer.gov/espanol or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).
Thursday, September 8, 2011
Beating enzyme to curb breast cancer?
Washington,
Sep 8 - Scientists in Singapore claim to have uncovered a new method to target
an enzyme that promotes the oestrogen receptor-negative breast cancer, a
finding which may pave the way for an effective treatment for the disease.
A team from the Genome Institute of Singapore
and the National University of Singapore says it has found the way to target
the enzyme EZH2 which puts people at risk of developing the oestrogen
receptor-negative breast cancer, one of the most aggressive forms of the
disease unresponsive to treatment.
According to them, the discovery may soon pave
the way to develop more effective treatment strategy for aggressive breast
cancers associated with EZH2.
It has been known that EZH2 enzymatic activity
promotes cancer by inactivating some important tumour suppressors, which
function as ÒbrakesÓ to stop tumour growth.
Over-expression
of EZH2 is often linked to aggressive and rapid spread of breast cancers, the
most common cancer in women all over the world.
Therefore, EZH2 is an ideal target for breast
cancer treatment, says the team whose findings have been published in the
'Molecular Cell' journal.
The team, led by Dr Qiang Yu, discovered that
besides inhibiting tumour suppressor genes through its enzyme activity, EZH2 is
also able to promote cancer through the activation of specific genes involved
in the cancer pathway, called NF-kB that is associated with the aggressive
oestrogen receptor- negative breast cancer.
These genes include inflammatory cytokines such as IL6 and IL8
which have important roles in breast cancer progression and cancer stem cell
self-renewal. In fact, the team discovered that the latter gene-activating
function of EZH2 does not require its enzyme activity.
ÒThis work suggests that EZH2 may confer its
oncogenic role in cancer not just through its gene silencing function of the
tumour suppressors but also through its gene activation function of NF-kB
pathway.
ÒThis new understanding on how EZH2 works as a
cancer-causing gene in breast cancer has important therapeutic implication, the
results suggest that small molecule drugs that block enzyme activity of EZH2
may not work for cancers caused by EZH2's activation genes in NF-kB pathway,Ó
said Yu.
Added team member Prof Cheng Wee Joo: ÒThis
work has important clinical implications. EZH2 is currently thought to cause
cancer through its enzymatic activity, hence inhibitors being developed mostly
target EZH2's enzymatic activity.
Monday, September 5, 2011
Now, a biocomputer to find and kill cancer cells
Washington, Sep 4 - Scientists
have developed a new DNA-based logic circuit which they say can identify and
kill cancer cells without harming the healthy ones.
The
researchers, who developed the cell-level diagnostic
system,
said it could be used for drug screening or perhaps
for
disease treatment, killing tumors while leaving healthy
cells
alone.
The
circuit, they said, works like any other logic
circuit:
It analyses multiple inputs and makes a decision.
In this
case, the circuit really consists of genes that
can detect
up to five cancer-specific molecules and their
concentrations.
When all five of those characteristics are
present,
the circuit makes a positive determination, and then
it
triggers cell death, they reported in the journal Science.
The
biocomputer combines the factors using logic
operations
such as AND and NOT, and only generates the
required
outcome, namely cell death, when the entire
calculation
with all the factors results in a logical TRUE
value,
lead researcher Yaakov Benenson, of Federal Institute
of
Technology in Zurich,
said in a statement.
The
researchers, including a team from the Massachusetts
Institute of Technology in the US, tested the biocomputer with
HeLa
cells, a prolific type of cervical cancer cell.
They
studied the cells' microRNA, which regulates gene
expression
by destroying messenger RNA, the substance that
brings the
DNA blueprint to the rest of the cell. They
eventually
pinpointed one microRNA combo that was unique to
HeLa
cells.
Once they
had the right combination, the researchers
designed a
synthetic gene which codes for a protein that
promotes
apoptosis, or programmed cell death. The special gene
would turn
on in the presence of miRNA levels that match the
HeLa profile.
If the
miRNA levels were too high or too low, the gene would not switch on, and the
cell would not be killed. Healthy cells, which would also lack the HeLa
profile, would be similarly left alone, the researchers said.
The next
step, they said, would be to test this system in
a living
animal, but this will be difficult. Current methods
use
viruses or chemicals to bring foreign DNA inside cells,
but these
make permanent changes, which could have their own
complications.
So the
method is still far from being usable for cancer
treatment,
they said, but added that it is an important step
toward
building a single-cell-level diagnostic method.
Subscribe to:
Posts (Atom)